Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Custom Assays Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Custom Assays industry at home and abroad, estimate the overall market scale of the Custom Assays industry and the market share of major countries, Custom Assays industry, and study and judge the downstream market demand of Custom Assays through systematic research, Analyze the competition pattern of Custom Assays, so as to help solve the pain points of various stakeholders in Custom Assays industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Custom Assays Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Custom Assays Market?
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Major Type of Custom Assays Covered in XYZResearch report:
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Application Segments Covered in XYZResearch Market
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Summary:
Get latest Market Research Reports on Custom Assays. Industry analysis & Market Report on Custom Assays is a syndicated market report, published as (Post-pandemic Era)-Global Custom Assays Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Custom Assays market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.